Our results suggest that NR6A1, CXCL5, C3, and TGFB1 are critical DEIRGs in sorafenib-resistant cells, which are markedly associated with the survival time of HCC patients and infiltration levels of immune cells. Here, CXCL5 is linked to hepatocellular carcinoma.